Artera develops multimodal artificial intelligence-based predictive and prognostic cancer tests to customize treatments for cancer patients.
Artera has raised $20.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.
Artera's investors include Coatue, EDBI, Walden Catalyst, Breyer Capital, AIspace Ventures.
Artera is headquartered in Los Altos, United States.
Artera develops multimodal artificial intelligence-based predictive and prognostic cancer tests to customize treatments for cancer patients.
Artera is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Artera — Funding & Investors." VCBacked, February 1, 2024, https://www.vcbacked.co/company/artera-los-altos. Accessed October 21, 2026.
VCBacked. (2024). Artera — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/artera-los-altos
{{cite web |title=Artera — Funding & Investors |url=https://www.vcbacked.co/company/artera-los-altos |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated